Danielle Brill Score: 43
Analyst at
Truist Financial
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+32.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
66%
23 W / 12 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
88%
22 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
16%
4 W / 21 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
4%
1 W / 24 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
78%
18 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
70%
23 W / 10 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 2 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 |
Solid Biosciences Inc
SLDB
|
BUY |
$20.00
Est. +120%
|
$9.10 | $10.48 |
Pending
|
$8.90
-2.2%
|
| Aug 18, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,095.00
Est. +11%
|
$987.84 | $1,072.75 |
Precision Hit (±3%)
|
$990.32
+0.3%
|
| Aug 12, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$107.00
Est. +28%
|
$83.89 | $84.99 |
Pending
|
$66.61
-20.6%
|
| Aug 05, 2026 |
Harmony Biosciences Holdings Inc
HRMY
|
SELL |
$34.00
Est. +13%
|
$39.28 | $37.43 (Low) |
Pending
|
$42.02
-7.0%
|
| May 27, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$542.00
Est. +24%
|
$435.93 | $560.25 |
Target Met
|
$508.14
+16.6%
|
| May 27, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$81.00
Est. +4%
|
$78.07 | $135.10 |
Target Met
|
$135.07
+73.0%
|
| Apr 29, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$102.00
Est. +46%
|
$70.08 | $93.42 |
Pending
|
$66.61
-5.0%
|
| Mar 17, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$83.00
Est. +19%
|
$69.85 | $135.10 |
Target Met
|
$135.07
+93.4%
|
| Feb 25, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$95.00
Est. +44%
|
$65.75 | $93.42 |
Precision Hit (±3%)
|
$66.61
+1.3%
|
| Feb 17, 2026 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$140.00
Est. +9%
|
$128.98 | $186.12 |
Target Met
|
$146.23
+13.4%
|
| Feb 09, 2026 |
Biogen Inc
BIIB
|
SELL |
$193.00
Est. +4%
|
$201.18 | $168.64 (Low) |
Target Met
|
$215.50
-7.1%
|
| Jan 12, 2026 |
Insmed Inc
INSM
|
BUY |
$205.00
Est. +23%
|
$166.26 | $175.12 |
Pending
|
$120.00
-27.8%
|
| Jan 08, 2026 |
Centessa Pharmaceuticals plc - ADR
CNTA
|
BUY |
$33.00
Est. +45%
|
$22.69 | $40.56 |
Target Met
|
$40.50
+78.5%
|
| Jan 08, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,030.00
Est. +25%
|
$822.94 | $1,072.75 |
Target Met
|
$990.32
+20.3%
|
| Jan 08, 2026 |
Tectonic Therapeutic Inc.
TECX
|
BUY |
$60.00
Est. +185%
|
$21.05 | $38.91 |
Pending
|
$27.00
+28.3%
|
| Dec 19, 2025 |
Insmed Inc
INSM
|
BUY |
$202.00
Est. +21%
|
$166.55 | $186.19 |
Pending
|
$120.00
-27.9%
|
| Nov 05, 2025 |
Centessa Pharmaceuticals plc - ADR
CNTA
|
BUY |
$30.00
Est. +57%
|
$19.15 | $40.56 |
Target Met
|
$40.50
+111.5%
|
| Oct 29, 2025 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$172.00
Est. +23%
|
$139.90 | $186.12 |
Target Met
|
$146.23
+4.5%
|
| Oct 14, 2025 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$56.00
Est. +63%
|
$34.42 | $116.45 |
Target Met
|
$96.81
+181.3%
|
| Oct 02, 2025 |
Palvella Therapeutics, Inc.
PVLA
|
BUY |
$80.00
Est. +30%
|
$61.69 | $160.47 |
Target Met
|
$150.56
+144.1%
|
| Jul 21, 2025 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$385.00
Est. +19%
|
$324.49 | $495.55 |
Target Met
|
$239.56
-26.2%
|
Solid Biosciences Inc
SLDB
Aug 21, 2026
Signal & Target
BUY
$20.00
Start Price
$9.10
Best Price (1Y)
$10.48
Current Price
$8.90
Return
-2.2%
Argen X SE - ADR
ARGX
Aug 18, 2026
Signal & Target
BUY
$1,095.00
Start Price
$987.84
Best Price (1Y)
$1,072.75
Current Price
$990.32
Return
+0.3%
BridgeBio Pharma Inc
BBIO
Aug 12, 2026
Signal & Target
BUY
$107.00
Start Price
$83.89
Best Price (1Y)
$84.99
Current Price
$66.61
Return
-20.6%
Harmony Biosciences Holdings Inc
HRMY
Aug 05, 2026
Signal & Target
SELL
$34.00
Start Price
$39.28
Best Price (1Y)
$37.43
Current Price
$42.02
Return
-7.0%
Vertex Pharmaceuticals, Inc.
VRTX
May 27, 2026
Signal & Target
BUY
$542.00
Start Price
$435.93
Best Price (1Y)
$560.25
Current Price
$508.14
Return
+16.6%
Apogee Therapeutics Inc.
APGE
May 27, 2026
Signal & Target
BUY
$81.00
Start Price
$78.07
Best Price (1Y)
$135.10
Current Price
$135.07
Return
+73.0%
BridgeBio Pharma Inc
BBIO
Apr 29, 2026
Signal & Target
BUY
$102.00
Start Price
$70.08
Best Price (1Y)
$93.42
Current Price
$66.61
Return
-5.0%
Apogee Therapeutics Inc.
APGE
Mar 17, 2026
Signal & Target
BUY
$83.00
Start Price
$69.85
Best Price (1Y)
$135.10
Current Price
$135.07
Return
+93.4%
BridgeBio Pharma Inc
BBIO
Feb 25, 2026
Signal & Target
BUY
$95.00
Start Price
$65.75
Best Price (1Y)
$93.42
Current Price
$66.61
Return
+1.3%
Neurocrine Biosciences, Inc.
NBIX
Feb 17, 2026
Signal & Target
BUY
$140.00
Start Price
$128.98
Best Price (1Y)
$186.12
Current Price
$146.23
Return
+13.4%
Biogen Inc
BIIB
Feb 09, 2026
Signal & Target
SELL
$193.00
Start Price
$201.18
Best Price (1Y)
$168.64
Current Price
$215.50
Return
-7.1%
Insmed Inc
INSM
Jan 12, 2026
Signal & Target
BUY
$205.00
Start Price
$166.26
Best Price (1Y)
$175.12
Current Price
$120.00
Return
-27.8%
Centessa Pharmaceuticals plc - ADR
CNTA
Jan 08, 2026
Signal & Target
BUY
$33.00
Start Price
$22.69
Best Price (1Y)
$40.56
Current Price
$40.50
Return
+78.5%
Argen X SE - ADR
ARGX
Jan 08, 2026
Signal & Target
BUY
$1,030.00
Start Price
$822.94
Best Price (1Y)
$1,072.75
Current Price
$990.32
Return
+20.3%
Tectonic Therapeutic Inc.
TECX
Jan 08, 2026
Signal & Target
BUY
$60.00
Start Price
$21.05
Best Price (1Y)
$38.91
Current Price
$27.00
Return
+28.3%
Insmed Inc
INSM
Dec 19, 2025
Signal & Target
BUY
$202.00
Start Price
$166.55
Best Price (1Y)
$186.19
Current Price
$120.00
Return
-27.9%
Centessa Pharmaceuticals plc - ADR
CNTA
Nov 05, 2025
Signal & Target
BUY
$30.00
Start Price
$19.15
Best Price (1Y)
$40.56
Current Price
$40.50
Return
+111.5%
Neurocrine Biosciences, Inc.
NBIX
Oct 29, 2025
Signal & Target
BUY
$172.00
Start Price
$139.90
Best Price (1Y)
$186.12
Current Price
$146.23
Return
+4.5%
Dianthus Therapeutics Inc
DNTH
Oct 14, 2025
Signal & Target
BUY
$56.00
Start Price
$34.42
Best Price (1Y)
$116.45
Current Price
$96.81
Return
+181.3%
Palvella Therapeutics, Inc.
PVLA
Oct 02, 2025
Signal & Target
BUY
$80.00
Start Price
$61.69
Best Price (1Y)
$160.47
Current Price
$150.56
Return
+144.1%
Alnylam Pharmaceuticals Inc
ALNY
Jul 21, 2025
Signal & Target
BUY
$385.00
Start Price
$324.49
Best Price (1Y)
$495.55
Current Price
$239.56
Return
-26.2%